A prediction model for childhood obesity in New Zealand

Éadaoin M Butler1,2, Avinesh Pillai3, Susan M B Morton1,3

  • 1A Better Start-National Science Challenge, Auckland, New Zealand.

Scientific Reports
|March 19, 2021
PubMed

Insights

A new model predicts childhood obesity in New Zealand using parental and infant data. While accurate, it has high false positive rates, potentially causing family anxiety.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Early childhood obesity is a growing concern globally and in New Zealand.
  • Existing obesity prediction models lack validation for New Zealand's diverse population.
  • Accurate prediction is crucial for timely and effective early intervention strategies.

Purpose of the Study:

  • To develop and validate a predictive model for obesity in 4-5-year-old children in New Zealand.
  • To utilize parental and infant data from the Growing Up in New Zealand (GUiNZ) cohort.
  • To assess the model's performance using internal and external validation cohorts.

Main Methods:

  • Data from the GUiNZ cohort (n=1731 derivation, n=713 internal validation) were used.
  • External validation was conducted using the Prevention of Overweight in Infancy (POI) and Pacific Islands Families (PIF) study cohorts.
  • The model incorporated birth weight, maternal smoking, maternal/paternal BMI, and infant weight gain.

Main Results:

  • The final prediction model demonstrated adequate discrimination accuracy (AUROC 0.74-0.80) across derivation and validation cohorts.
  • Positive predictive values were generally low, indicating a high rate of false positives.
  • The PIF cohort showed more consistent, though still variable, positive predictive values (52-61%).

Conclusions:

  • The developed model can aid in early childhood obesity prediction for New Zealand children.
  • High false positive rates necessitate careful consideration to avoid unwarranted parental anxiety.
  • Further refinement may be needed to improve the model's positive predictive value for clinical application.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
896
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.4K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
177
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
1.8K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
166